Literature DB >> 30878797

Associations of serum CRP levels with demographics, health behaviors, and risk of cancer among the Mexican American Mano A Mano Cohort.

Jie Shen1, Daphne Hernandez2, Lorna Haughton McNeill3, Wong-Ho Chow1, Hua Zhao4.   

Abstract

C-Reactive protein (CRP) is a well-known inflammatory marker, and elevated CRP levels has been reported to be associated with the risk of various cancers. To date, no study has investigated the association between elevated CRP and incidents of cancer among Mexican Americans. In the current prospective cohort study, we measured pre-diagnostic CRP levels in serum samples and evaluated their relationships with demographic characteristics and health behaviors associated with cancer risk among 2753 Mexican Americans selected from the Mano-A-Mano Mexican American Cohort Study. At baseline, median levels of serum CRP significantly differed by demographics (sex, age category, marital status, and education levels) and health behaviors (cigarette smoking status, alcohol drinking status, BMI category, and physical activity levels). In the multivariable analysis, the study participants who were women, older, never drinking alcohol, overweight or obese, and physically inactive had increased likelihood of having high CRP levels (≥ median levels among all study participants) compared to their counterparts. A total of 177 cancer cases were identified during the follow-up with a median follow-up time of 127 months. In the quartile analysis, study participants in the 4th quartile with highest CRP levels had significantly 1.88 fold increased risk of cancer (hazard ratio (HR) = 1.88, 95%CI: 1.12, 3.13) compared to those in the 1st quartile with lowest CRP levels. The association was further confirmed in analyses using clinical CRP levels. In summary, our findings suggested that serum CRP levels have potential to serve as a predictive marker of cancer risk in Mexican Americans.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRP; Cancer risk; Mexican Americans

Mesh:

Substances:

Year:  2019        PMID: 30878797     DOI: 10.1016/j.canep.2019.03.001

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  4 in total

1.  Association of Allostatic Load and All Cancer Risk in the SWAN Cohort.

Authors:  Jie Shen; Bernard F Fuemmeler; Yufan Guan; Hua Zhao
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

2.  Homologous recombination repair capacity in peripheral blood lymphocytes and breast cancer risk.

Authors:  Jie Shen; Renduo Song; Wong-Ho Chow; Hua Zhao
Journal:  Carcinogenesis       Date:  2020-10-15       Impact factor: 4.944

3.  Biological Aging Marker p16INK4a in T Cells and Breast Cancer Risk.

Authors:  Jie Shen; Renduo Song; Bernard F Fuemmeler; Kandace P McGuire; Wong-Ho Chow; Hua Zhao
Journal:  Cancers (Basel)       Date:  2020-10-26       Impact factor: 6.639

4.  Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease.

Authors:  Eriko Yasutomi; Toshihiro Inokuchi; Sakiko Hiraoka; Kensuke Takei; Shoko Igawa; Shumpei Yamamoto; Masayasu Ohmori; Shohei Oka; Yasushi Yamasaki; Hideaki Kinugasa; Masahiro Takahara; Keita Harada; Masaki Furukawa; Kouichi Itoshima; Ken Okada; Fumio Otsuka; Takehiro Tanaka; Toshiharu Mitsuhashi; Jun Kato; Hiroyuki Okada
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.